Get the Stockscreener App
2.25
5.14%
0.11
After Hours:
2.25
Cibus Inc stock is traded at $2.25, with a volume of 75,165.
It is up +5.14% in the last 24 hours and up +17.80% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$2.14
Open:
$2.19
24h Volume:
75,165
Relative Volume:
0.50
Market Cap:
$62.99M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.1116
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
+16.58%
1M Performance:
+17.80%
6M Performance:
-48.86%
1Y Performance:
-86.56%
1-Day Range:
$2.19
$2.38
1-Week Range:
$1.90
$2.38
52-Week Range:
$1.40
$19.56
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
2.25 | 62.99M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.15 | 126.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.61 | 65.06B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
649.67 | 37.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.39 | 32.56B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
255.77 | 26.40B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Cibus director Prante sells $2,875 in stock - MSN
Cibus (CBUS) Expected to Announce Earnings on Thursday - MarketBeat
Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Geode Capital Management LLC Has $1.09 Million Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
USDA-APHIS Designates Cibus' Disease Resistance Traits for Gene-Edited Canola as Not Regulated - ISAAA.org
Press Release Distribution & PR Platform - ACCESS Newswire
Cibus to Report First Quarter 2025 Financial Results on May 8, 2 - GuruFocus
Cibus director Gerhard Prante sells shares worth $2,852 - MSN
Cibus director Gerhard Prante sells shares worth $2,932 - MSN
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and ... - Leader-Telegram
Agricultural Biotech Leader Cibus Sets Q1 2025 Earnings Release: Key Gene Editing Updates Expected - Stock Titan
Cibus announces USDA-APHIS designated two products as not regulated - TipRanks
Cibus (CBUS) Canola Traits Receive USDA Non-Regulated Status | C - GuruFocus
USDA-APHIS Designates Additional Cibus' Disease Resistance Trait Products as Not Regulated | CBUS Stock News - GuruFocus
USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated - Leader-Telegram
USDA Approves Cibus Gene-Edited Canola Traits That Combat 50% Crop Loss | CBUS Stock News - Stock Titan
Cibus director Gerhard Prante sells $2,806 in stock - MSN
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Raymond James Financial Inc. Invests $89,000 in Cibus, Inc. (NASDAQ:CBUS) - Defense World
17,744 Shares in Cibus, Inc. (NASDAQ:CBUS) Acquired by Sei Investments Co. - Defense World
Commonwealth Equity Services LLC Purchases Shares of 22,201 Cibus, Inc. (NASDAQ:CBUS) - Defense World
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Corient Private Wealth LLC Sells 60,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Charles Schwab Investment Management Inc. Sells 7,726 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline - Investing.com Australia
Research Analysts Offer Predictions for Cibus Q1 Earnings - MarketBeat
HC Wainwright Reiterates Buy Rating for Cibus (NASDAQ:CBUS) - MarketBeat
Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 - MSN
What is HC Wainwright’s Forecast for Cibus Q1 Earnings? - Defense World
Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright - Defense World
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges - TipRanks
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - Yahoo Finance
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc. Reports Progress in Gene Editing and Financial Results - TipRanks
Cibus: Q4 Earnings Snapshot - mySA
Earnings call transcript: Cibus Inc. Q4 2024 focuses on innovation and cost-saving - Investing.com India
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus: Q4 Earnings Snapshot -March 20, 2025 at 06:00 pm EDT - MarketScreener
Cibus Inc. (CBUS) reports earnings - Quartz
Cibus Reports Fourth Quarter Financial Results And Provides Business Update -March 20, 2025 at 04:54 pm EDT - Marketscreener.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
2.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):